Zen Chu

Zen Chu

Signal active

Founder Senior Lecturer, Faculty Director for MIT HST.978 Healthcare Ventures + MIT Hacking Medicine

Bio

Zen Chu believes that now is the best time in history for healthcare entrepreneurs and engineers to create the data, systems and products to help medicine scale and serve more patients with higher quality at lower cost. He created and teaches the MIT Healthcare Ventures graduate courses within the pioneering Health Science & Technology (HST) program, a joint initiative between MIT, Harvard Medical School and the Boston academic hospitals. As faculty director for the HackingMedicine.MIT.edu health innovation leadership initiatives, Zen mentors physician entrepreneurs, early-stage startups and health corporations adapting to global digital healthcare transformation, changing healthcare incentives, growth in emerging markets, and new disruptive technologies that re-engineer medicine.

As Managing Director of Accelerated Medical Ventures, Zen specializes in building early-stage medical technology and healthcare service companies, usually serving as co-founder and first investor. AMV’s portfolio spans Boston, Silicon Valley and China, including PillPack.com, Figure1.com, 3D-Matrix Medical [JASDAQ: 7777], Curoverse Genomics, PathFinder Regenerative Medicine [OTCQB: PFND], BitGym.com, Aptible, DirectDermatology.com and a couple of companies still in stealth mode.

Alongside four world-renowned MIT biomaterials professors, Zen co-founded 3D-Matrix Medical Inc., serving as the first CEO for the venture-backed MIT regenerative medicine company whose injectable gel drug delivery products are treating patients and enabling new regenerative medicine research, with a successful IPO in 2011. He has managed and led new ventures for Harvard Medical School, Harvard’s Wyss Institute for Bioengineering, NetVentures and Hewlett-Packard.

Zen earned a Masters of Public & Private Management from Yale University and a BS in biomedical/electrical engineering from SMU.  He's married to Katie Rae, another entrepreneur-turned-venture investor and they are raising three aspiring makers in Brookline, MA.

Location

Cambridge, Massachusetts, United States, North America

Social

Primary Organization

Massachusetts Institute of Technology

Massachusetts Institute of Technology

Founded

1861

Investment

25

Lead investment

9

Exits

5

Employees

10001+

Industry

Education, Higher Education, Universities

Jobs history

4

Apex Neuro

Founder

2016 - Current

Abridge

Board Director

2019 - Current

Apex Neuro

Chairman of the Board

2016 - Current

Feelmore Labs

Co-Founder

2016 - Current

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Zen Chu is the Founder Senior Lecturer, Faculty Director for MIT HST.978 Healthcare Ventures + MIT Hacking Medicine at Massachusetts Institute of Technology, based in United States, North America. With a background in Education, Zen Chu has a rich history of leadership and innovation. Zen Chu studied Master's Public & Private Management @ Yale University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

Daniel Debow

Daniel Debow

VP, Product (Demand)

Jevon MacDonald

Jevon MacDonald

Co-Founder

Lucy McAllister

Lucy McAllister

No designation

Walter Winshall

Walter Winshall

Founder

Andy Palmer

Andy Palmer

Co-Founder and Chairperson

Sridhar Iyengar

Sridhar Iyengar

Founder & CEO

Investment portfolio

Zen Chu has made 4 investments. Their Latest investment was Series A - MycoMedica Life Sciences, PBC on Jun 01, 2022

Number of investment

4

Number of exits

2

Personal investment

4

Annouced DateOrganization NameFunding RoundMoney Raised
Jul 01, 2013
PillPack PillPack
Series A - PillPack
3.5M
Dec 09, 2013
Figure 1 Figure 1
Seed Round - Figure 1
2.0M
Oct 06, 2020
Abridge Abridge
Series A - Abridge
10.0M
Jun 01, 2022
MycoMedica Life Sciences, PBC MycoMedica Life Sciences, PBC
Series A - MycoMedica Life Sciences, PBC
60.0M

Partner investment

2

Annouced DateOrganization NameFunding RoundInvestor NameMoney Raised
Oct 29, 2018-
Seed Round - Filtricine
Zen Chu
5.0M
Jun 01, 2022
MycoMedica Life Sciences, PBC MycoMedica Life Sciences, PBC
Series A - MycoMedica Life Sciences, PBC
MycoMedica Life Sciences, PBC Zen Chu
60.0M

Exits

2

exit.name Figure 1

Figure 1

Figure 1 connects healthcare professionals around the world to view, discuss, and share medical cases. It now has a glob...

Invest in industries

Recent Activity

There is no recent news or activity for this profile.